When the PPAR-γ gene (PPARG) is mutated, variant PPAR-γ exerts counter-regulatory effects on TGF-β, which leads to anti-fibrotic effects in systemic sclerosis (SSc) [74]. Here, TGFB1 is linked to systemic sclerosis.